Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Eissing

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|June 23, 2004
Bistability analyses of a caspase activation model for receptor-induced apoptosisThomas Eissing, Holger Conzelmann, Ernst D Gilles, et al.
Frontiers in Immunology|May 11, 2017
Physiologically Based Simulations of Deuterated Glucose for Quantifying Cell Turnover in HumansJulio Lahoz-Beneytez, Stephan Schaller, Derek Macallan, et al.
IEEE Transactions on Bio-Medical Engineering|November 10, 2015
Robust PBPK/PD-Based Model Predictive Control of Blood GlucoseStephan Schaller, Jorg Lippert, Lukas Schaupp, et al.
Clinical Pharmacokinetics|January 1, 2017
Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic PatientsChristian Radke, Dagmar Horn, Christian Lanckohr, et al.
Clinical Pharmacokinetics|April 10, 2017
Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant WomenAndré Dallmann, Ibrahim Ince, Juri Solodenko, et al.
FEMS Yeast Research|April 19, 2003
Regulation of the yeast glycine cleavage genes is responsive to the availability of multiple nutrientsMatthew D W Piper, Seung Pyo Hong, Thomas Eissing, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 10, 2018
PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and DigoxinNina Hanke, Sebastian Frechen, Daniel Moj, et al.
Clinical Pharmacokinetics|June 29, 2016
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly IndividualsJan-Frederik Schlender, Michaela Meyer, Kirstin Thelen, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 17, 2019
Application of Physiologically-Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of MoxifloxacinStefan Willmann, Matthias Frei, Gabriele Sutter, et al.
Clinical Pharmacokinetics|May 27, 2019
Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug-Drug-Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and ItraconazoleDenise Türk, Nina Hanke, Sarah Wolf, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|June 23, 2004
Bistability analyses of a caspase activation model for receptor-induced apoptosisThomas Eissing, Holger Conzelmann, Ernst D Gilles, et al.
Frontiers in Immunology|May 11, 2017
Physiologically Based Simulations of Deuterated Glucose for Quantifying Cell Turnover in HumansJulio Lahoz-Beneytez, Stephan Schaller, Derek Macallan, et al.
IEEE Transactions on Bio-Medical Engineering|November 10, 2015
Robust PBPK/PD-Based Model Predictive Control of Blood GlucoseStephan Schaller, Jorg Lippert, Lukas Schaupp, et al.
Clinical Pharmacokinetics|January 1, 2017
Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic PatientsChristian Radke, Dagmar Horn, Christian Lanckohr, et al.
Clinical Pharmacokinetics|April 10, 2017
Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant WomenAndré Dallmann, Ibrahim Ince, Juri Solodenko, et al.
FEMS Yeast Research|April 19, 2003
Regulation of the yeast glycine cleavage genes is responsive to the availability of multiple nutrientsMatthew D W Piper, Seung Pyo Hong, Thomas Eissing, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 10, 2018
PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and DigoxinNina Hanke, Sebastian Frechen, Daniel Moj, et al.
Clinical Pharmacokinetics|June 29, 2016
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly IndividualsJan-Frederik Schlender, Michaela Meyer, Kirstin Thelen, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 17, 2019
Application of Physiologically-Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of MoxifloxacinStefan Willmann, Matthias Frei, Gabriele Sutter, et al.
Clinical Pharmacokinetics|May 27, 2019
Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug-Drug-Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and ItraconazoleDenise Türk, Nina Hanke, Sarah Wolf, et al.
Pageof 5